Women with genotype AG of SNP -2548 G/A of leptin are less likely to be at risk for endometrial cancer given that the heterozygote AG is less frequently observed in endometrial cancer patients (Bienkiewicz et al., 2017). The gene discussed is LEP; the disease is endometrial cancer.